Vaxenta Biotechnologies, a biotechnology company dedicated to finding the cure for cancer through the development of therapeutic vaccines, announced today the recruitment of Howard Leonhardt to the company’s scientific and professional advisory board. Mr. Leonhardt, inventor of the TALENT aortic stent graft, holds over 20 patents and has extensive business experience; he founded and led World Medical Mfg. Corp. in 1988, which grew from 3 employees to 550, merged with AVE of California, and sold to Medtronic in 1999.
Help employers find you! Check out all the jobs and post your resume.
